CRITTENDEN M - Search Results

1

End results and mortality trends in cancer. II. Cancer mortality trends in the United States, 1930-1955.

GORDON T, CRITTENDEN M, HAENSZEL W. GORDON T, et al. Among authors: crittenden m. Natl Cancer Inst Monogr. 1961 Sep;6:133-350. Natl Cancer Inst Monogr. 1961. PMID: 13900501 No abstract available.

2

Distribution of primary lung carcinomas in relation to time as determined by histochemical techniques.

HERMAN DL, CRITTENDEN M. HERMAN DL, et al. Among authors: crittenden m. J Natl Cancer Inst. 1961 Dec;27:1227-71. J Natl Cancer Inst. 1961. PMID: 13906689 No abstract available.

3

Studies on the epidemiology of bovine leukemia.

Conner GH, LaBelle JA, Langham RF, Crittenden M. Conner GH, et al. Among authors: crittenden m. J Natl Cancer Inst. 1966 Mar;36(3):383-8. J Natl Cancer Inst. 1966. PMID: 18630315

4

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.

Baird JR, Bell RB, Troesch V, Friedman D, Bambina S, Kramer G, Blair TC, Medler T, Wu Y, Sun Z, de Gruijl TD, van de Ven R, Leidner RS, Crittenden MR, Gough MJ. Baird JR, et al. Cancer Res. 2018 Nov 1;78(21):6308-6319. doi: 10.1158/0008-5472.CAN-18-1652. Epub 2018 Sep 17. Cancer Res. 2018. PMID: 30224374

5

Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.

Bell RB, Leidner R, Feng Z, Crittenden MR, Gough MJ, Fox BA. Bell RB, et al. J Oral Maxillofac Surg. 2015 Dec;73(12 Suppl):S107-15. doi: 10.1016/j.joms.2015.05.026. J Oral Maxillofac Surg. 2015. PMID: 26608138 Review. No abstract available.

6

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.

Bell RB, Leidner RS, Crittenden MR, Curti BD, Feng Z, Montler R, Gough MJ, Fox BA, Weinberg AD, Urba WJ. Bell RB, et al. Oral Oncol. 2016 Jan;52:1-10. doi: 10.1016/j.oraloncology.2015.11.009. Epub 2015 Nov 21. Oral Oncol. 2016. PMID: 26614363 Review.

7

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.

Bryan RB, Gough MJ, Seung SK, Jutric Z, Weinberg AD, Fox BA, Crittenden MR, Leidner RS, Curti B. Bryan RB, et al. Oral Oncol. 2016 Oct;61:166-76. doi: 10.1016/j.oraloncology.2016.08.020. Epub 2016 Sep 7. Oral Oncol. 2016. PMID: 27614589 Review.

8

STING expression and response to treatment with STING ligands in premalignant and malignant disease.

Baird JR, Feng Z, Xiao HD, Friedman D, Cottam B, Fox BA, Kramer G, Leidner RS, Bell RB, Young KH, Crittenden MR, Gough MJ. Baird JR, et al. PLoS One. 2017 Nov 14;12(11):e0187532. doi: 10.1371/journal.pone.0187532. eCollection 2017. PLoS One. 2017. PMID: 29135982 Free PMC article.

9

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.

Crittenden MR, Zebertavage L, Kramer G, Bambina S, Friedman D, Troesch V, Blair T, Baird JR, Alice A, Gough MJ. Crittenden MR, et al. Sci Rep. 2018 May 3;8(1):7012. doi: 10.1038/s41598-018-25482-w. Sci Rep. 2018. PMID: 29725089 Free PMC article.

10

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.

Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, Patel AA, Cheng AC, Watters AL, Bifulco C, Morris G, Rushforth L, Nemeth S, Urba WJ, Gough M, Bell RB. Leidner R, et al. Among authors: crittenden m. J Immunother Cancer. 2021 May;9(5):e002485. doi: 10.1136/jitc-2021-002485. J Immunother Cancer. 2021. PMID: 33963014 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters